MedTrace Logo

Echocardiography During Ajmaline Test

NCT03491475 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-04-09

No results posted yet for this study

Summary

In this study the investigators analyse echocardiographic images before and during Ajmaline test. The purpose is to know if any echocardiographic modifications are present during either negative or positive Ajmaline testing.

Conditions

  • Brugada Syndrome

Interventions

DRUG

Ajmaline test

Administration of Ajmaline

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Esther Scheirlynck, MD · Universitair Ziekenhuis Brussel

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-26
Primary Completion
2019-03-31
Completion
2019-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491475 on ClinicalTrials.gov